MTNB Financials

Matinas BioPharma Holdings Inc - Financial statements & key metrics

Stock Price

$0.20

Market Cap

$5.59M

P/E Ratio

-0.0

EPS

$-3.42

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-24.25M

EPS (Diluted)

$-4.98

Balance Sheet Highlights

Total Assets

$12.64M

Total Liabilities

$5.05M

Shareholders Equity

Cash & Equivalents

$7.28M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-15.88M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-151.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is MTNB revenue?

View MTNB's income statement for detailed revenue data.

Is MTNB profitable?

MTNB reported a loss of $24.25M in the most recent quarter.

What is MTNB market cap?

MTNB has a market capitalization of $5.59M, making it a small-cap stock.

Does MTNB have debt?

View MTNB's balance sheet for debt information.

What is MTNB cash flow?

Cash flow data is available in the full financial statements.